The global market for Oral Antiviral Medicines for COVID-19 is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Oral Antiviral Medicines for COVID-19 market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Oral Antiviral Medicines for COVID-19 market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Oral Antiviral Medicines for COVID-19 market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Oral Antiviral Medicines for COVID-19 market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Oral Antiviral Medicines for COVID-19 players cover Pfizer, Merck, Shionogi, Simcere Pharmaceutical and Frontier Biotechnologies and etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Oral Antiviral Medicines for COVID-19 market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Oral Antiviral Medicines for COVID-19 market, with both quantitative and qualitative data, to help readers understand how the Oral Antiviral Medicines for COVID-19 market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in Units.
Market Segmentation:
The study segments the Oral Antiviral Medicines for COVID-19 market and forecasts the market size by Type (Lagevrio, Paxlovid and Azvudine), by Application (Aldult and Elder.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Lagevrio
Paxlovid
Azvudine
Segmentation by application
Aldult
Elder
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Pfizer
Merck
Shionogi
Simcere Pharmaceutical
Frontier Biotechnologies
Kexing Biopharm
Chapter Introduction
Chapter 1: Scope of Oral Antiviral Medicines for COVID-19, Research Methodology, etc.
Chapter 2: Executive Summary, global Oral Antiviral Medicines for COVID-19 market size (sales and revenue) and CAGR, Oral Antiviral Medicines for COVID-19 market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Oral Antiviral Medicines for COVID-19 sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Oral Antiviral Medicines for COVID-19 sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Oral Antiviral Medicines for COVID-19 market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Pfizer, Merck, Shionogi, Simcere Pharmaceutical, Frontier Biotechnologies and Kexing Biopharm, etc.
Chapter 14: Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Oral Antiviral Medicines for COVID-19. Industry analysis & Market Report on Oral Antiviral Medicines for COVID-19 is a syndicated market report, published as Global Oral Antiviral Medicines for COVID-19 Market Growth 2022-2028. It is complete Research Study and Industry Analysis of Oral Antiviral Medicines for COVID-19 market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.